Medical Studies

​

Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors

​

Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres May 2021

 

Breast Cancer Research and Treatment, 2018: Persistent Major Alopecia Following Adjuvant Docetaxel for Breast Cancer: Incidence, Characteristics, and Prevention with Scalp Cooling

​

Supportive Care in Cancer, 2015: Measurement of Chemotherapy-Induced Alopecia—Time to Change

​

International Journal of Endocrinology & Metabolism, 2013:
Female Pattern Hair Loss

​

Annals of Oncology, 2012:
Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy

​

Journal of the American Academy of Dermatology, 2011:
Permanent Chemotherapy-Induced Alopecia: A Review

​

Journal of the American Academy of Dermatology, 2010:
Permanent chemotherapy-induced alopecia: Case Report and Review of the Literature

​

Interview with Dr. Scot Sedlacek, Oncologist, Rocky Mountain Cancer Centers

​

Journal of Health Psychology, 2008:
Women’s Experiences of an Altered Appearance during Chemotherapy: An Indication of Cancer Status

​

European Journal of Oncology Nursing, 2007:
Anticipating an Altered Appearance: Women Undergoing Chemotherapy Treatment for Breast Cancer

​

Rocky Mountain Cancer Centers

​

FDA Warning Letter, 2009

​

Supportive Care in Cancer, 1997:
Changes in Self-Concept and Body Image During Alopecia Induced Cancer Chemotherapy

​

Breast Cancer Research and Treatment, 2018: Persistent Major Alopecia Following Adjuvant Docetaxel for Breast Cancer: Incidence, Characteristics, and Prevention with Scalp Cooling

​

​

alopecia, breast cancer, docetaxel, hair loss,  paclitaxel,  taxane, Taxotere, chemotherapy